BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

The technologies licensed to Telethon are based on Takara Bio’s proprietary RetroNectin® method, which includes a technology enabling highly effi...

October 05, 2023 | News

Mabwell Starts Phase Ib/II Trial for Nectin-4 ADC with PD-1 Inhibitor

The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...

September 29, 2023 | News

SGC and HitGen Partner for DNA-Encoded Drug Discovery

HitGen will utilize its DNA-encoded library (DEL) technology platform, specifically OpenDEL™, to screen under-represented targets chosen by SGC. &nbs...

September 29, 2023 | News

Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs Sa...

September 29, 2023 | News

Seven AI/ML Life Sciences Innovators in Clarivate's Watchlist

United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery C...

September 28, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

September 26, 2023 | News

Johnson & Johnson Innovation Collaborates with Singapore EDB to Boost Life Science Innovation

Johnson & Johnson International (Singapore) Pte. Ltd.announced a collaboration with the Singapore Economic Development Board (EDB) to un...

September 26, 2023 | News

Lynk Pharmaceuticals Secures 322 Million RMB in Series C2 Funding

This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperi...

September 22, 2023 | News

Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets

"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...

September 21, 2023 | News

Cerecin strengthens position in neurometabolism with addition to pipeline

Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for development and use in positron emission tomography (...

September 20, 2023 | News

deCODE Genetics and Collaborators Reveal Complex Impact of Sequence Variants on Lipid Levels and Heart Disease

Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and The Copenhagen University,...

September 15, 2023 | News

Cure Genetics and Frametact Strike $60M Deal for Familial Neurological Disease Gene Therapy

The partnership will leverage Cure Genetics' proprietary VELP™ platform to develop novel Adeno-Associated Virus (AAV) vectors for the treatment of fa...

September 15, 2023 | News

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....

September 14, 2023 | News

Roche Diagnostics and Burjeel Holdings Join Forces for Enhanced Digital Diagnostics and Patient Care

Roche Diagnostics Middle East FZCO, a global leader in diagnostics, and Burjeel Holdings, one of the largest healthcare services providers in the MENA regi...

September 11, 2023 | News

Stay Connected